RE:RE:RE:RE:The issue of the safe use of higher doses of vaccinia virus Correction: - Takeda is walking away from a 2019 bio-buck deal with Turnstone Biologics, that included a $120 million up-front payment for Turnstone's vaccinia virus cancer prospect.